Team

PhD 1990, in Immunochemistry at University Louis Pasteur, Strasbourg; post-doc at DKFZ, Heidelberg, Germany. She develops her research activity at Inserm. Her team is involved in the characterization of humoral responses in HIV. She was pioneer in investigating the various Fc-mediated inhibitory functions of non-neutralizing HIV-1 specific antibodies to be induced in addition or as alternative to neutralizing antibodies with the aim to develop new vaccination strategies. She has created a neutralizing antibody platform in which experiments are performed under GcLP (good clinical laboratory practices) conditions. She notably participated in the standardization of neutralization assays and is a member of various coordinated actions at the national and international within several consortia and European funded projects. Her team was involved in numerous antiviral development to increase efficacy, limit resistance and study synergistic effects of antiviral compounds.Notably, she is incharge of the evaluation of humoral responses in clinical trial testing VRI’s HIV vaccine.